These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 8393143)

  • 21. Hormone-dependent and -independent transcriptional activation by thyroid hormone receptors are mediated by different mechanisms.
    Helmer EB; Raaka BM; Samuels HH
    Endocrinology; 1996 Feb; 137(2):390-9. PubMed ID: 8593781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Naturally occurring genotypes of the human immunodeficiency virus type 1 long terminal repeat display a wide range of basal and Tat-induced transcriptional activities.
    Michael NL; D'Arcy L; Ehrenberg PK; Redfield RR
    J Virol; 1994 May; 68(5):3163-74. PubMed ID: 7908701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in transcriptional enhancers of HIV-1 and HIV-2. Response to T cell activation signals.
    Tong-Starksen SE; Welsh TM; Peterlin BM
    J Immunol; 1990 Dec; 145(12):4348-54. PubMed ID: 2258623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro transcriptional studies of the roles of the thyroid hormone (T3) response elements and minimal promoters in T3-stimulated gene transcription.
    Suen CS; Yen PM; Chin WW
    J Biol Chem; 1994 Jan; 269(2):1314-22. PubMed ID: 8288596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcription factor PRDII-BF1 activates human immunodeficiency virus type 1 gene expression.
    Seeler JS; Muchardt C; Suessle A; Gaynor RB
    J Virol; 1994 Feb; 68(2):1002-9. PubMed ID: 8289330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein.
    Kamine J; Subramanian T; Chinnadurai G
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8510-4. PubMed ID: 1924310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drastic decrease of transcription activity due to hypermutated long terminal repeat (LTR) region in different HIV-1 subtypes and recombinants.
    de Arellano ER; Alcamí J; López M; Soriano V; Holguín A
    Antiviral Res; 2010 Nov; 88(2):152-9. PubMed ID: 20713090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Second-site long terminal repeat (LTR) revertants of replication-defective human immunodeficiency virus: effects of revertant TATA box motifs on virus infectivity, LTR-directed expression, in vitro RNA synthesis, and binding of basal transcription factors TFIID and TFIIA.
    Kashanchi F; Shibata R; Ross EK; Brady JN; Martin MA
    J Virol; 1994 May; 68(5):3298-307. PubMed ID: 8151790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Basal and Tat-transactivated expression from the human immunodeficiency virus type 1 long terminal repeat in human placental trophoblast rules out promoter-enhancer activation as the partial block to viral replication.
    Zachar V; Ebbesen P; Thomas RA; Zacharova V; Goustin AS
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1461-8. PubMed ID: 8207411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The c-rel protooncogene product represses NF-kappa B p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus.
    Doerre S; Sista P; Sun SC; Ballard DW; Greene WC
    Proc Natl Acad Sci U S A; 1993 Feb; 90(3):1023-7. PubMed ID: 8430069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Half-site arrangement of hybrid glucocorticoid and thyroid hormone response elements specifies thyroid hormone receptor complex binding to DNA and transcriptional activity.
    Yen PM; Ikeda M; Wilcox EC; Brubaker JH; Spanjaard RA; Sugawara A; Chin WW
    J Biol Chem; 1994 Apr; 269(17):12704-9. PubMed ID: 8175681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional evidence for ligand-dependent dissociation of thyroid hormone and retinoic acid receptors from an inhibitory cellular factor.
    Casanova J; Helmer E; Selmi-Ruby S; Qi JS; Au-Fliegner M; Desai-Yajnik V; Koudinova N; Yarm F; Raaka BM; Samuels HH
    Mol Cell Biol; 1994 Sep; 14(9):5756-65. PubMed ID: 8065310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An NF-kappaB site in the 5'-untranslated leader region of the human immunodeficiency virus type 1 enhances the viral expression in response to NF-kappaB-activating stimuli.
    Mallardo M; Dragonetti E; Baldassarre F; Ambrosino C; Scala G; Quinto I
    J Biol Chem; 1996 Aug; 271(34):20820-7. PubMed ID: 8702837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ligand-binding domains of the thyroid hormone/retinoid receptor gene subfamily function in vivo to mediate heterodimerization, gene silencing, and transactivation.
    Qi JS; Desai-Yajnik V; Greene ME; Raaka BM; Samuels HH
    Mol Cell Biol; 1995 Mar; 15(3):1817-25. PubMed ID: 7862171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
    McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
    Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of the human immunodeficiency virus type 1 long terminal repeat by transforming mutants of human p53.
    Subler MA; Martin DW; Deb S
    J Virol; 1994 Jan; 68(1):103-10. PubMed ID: 8254719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Essential role of NF-kappa B in transactivation of the human immunodeficiency virus long terminal repeat by the human cytomegalovirus 1E1 protein.
    Kim S; Yu SS; Kim VN
    J Gen Virol; 1996 Jan; 77 ( Pt 1)():83-91. PubMed ID: 8558131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Linker-scanning mutational analysis of the transcriptional activity of the human immunodeficiency virus type 1 long terminal repeat.
    Zeichner SL; Kim JY; Alwine JC
    J Virol; 1991 May; 65(5):2436-44. PubMed ID: 2016766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of HIV-1 gene expression by NF-IL6.
    Tesmer VM; Bina M
    J Mol Biol; 1996 Sep; 262(3):327-35. PubMed ID: 8844998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Half-site spacing and orientation determines whether thyroid hormone and retinoic acid receptors and related factors bind to DNA response elements as monomers, homodimers, or heterodimers.
    Forman BM; Casanova J; Raaka BM; Ghysdael J; Samuels HH
    Mol Endocrinol; 1992 Mar; 6(3):429-42. PubMed ID: 1316541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.